Article Details
Retrieved on: 2022-03-13 05:00:14
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
London and Redwood City, Calif., March 3, 2022 - Mereo BioPharma Group plc (NASDAQ: MREO) ("Mereo" or "the Company"), a clinical stage ...
Article found on: www.marketscreener.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here